Hummingbirds’ Portfolio

FAST-TRACK development of innovative RM therapies

We enable innovative tissue and cell therapies to cure chronic and metabolic diseases. Hummingbird is always looking to find new, innovative opportunities in the RM field. We are currently assessing multiple tissue and cell therapy innovations in the fields of:

Neurodegenerative
Kidney
Oncology
Cartilage
Diabetes
Hair & Skin
Cardiovascular

With our expertise in regenerative therapy development, access to funding and multiple manufacturing facilities around the world, we aim to transform the small, local therapy development companies into global companies.

Our Facilities

AUTOMATED AND UP-SCALED manufacturing infrastructure for regenerative medicine therapies

Hummingbird Lab comprises three state-of-the-art facilities across the globe, strategically located in the EU, USA and MENA (under development) regions. Our mission is to revolutionize cell and tissue therapy production, making these therapies more efficient and affordable for all patients by leveraging our automated and scalable manufacturing platform.

At Hummingbird Lab, our facilities are equipped with a cutting-edge manufacturing platform to optimize and automate the production of preclinical, clinical, and commercial cell and tissue therapies and deliver on comprehensive CDMO capabilities. Furthermore, we tailor our facilities to the region’s needs in the regenerative medicine field, collaborating with local stakeholders to provide additional services such as regulatory support or employee training.

Our facilities offer regionally tailored combination of:

Contract Development & Manufacturing Organization (CDMO) capabilities include cell bank, process development, production of pre-clinical materials and clinical materials
Fast track implementation of automated manufacturing and GMP processes
Accelerate development of (allogenic) cell and tissue therapies through upscaled manufacturing with access to centralized funding and expertise
Access to high potential startups, and high impact emerging regenerative medicine healthcare technologies

Our Hummingbird Leadership Team, operates through a hub-and-spoke model to identify and manage strategic opportunities globally. With expertise in various different disciplines, we navigate worldwide trends, build strong partnerships, and make investments in the RM and biologics field. This structure allows us to stay agile and responsive across key markets, ensuring sustainable growth and long-term value for Hummingbird and its’ partners.